Amarin (AMRN): Potential Takeout And Positive Rx Trends Support Positive Thesis - Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $35 price target on Amarin Corporation (NASDAQ: AMRN) on potential ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
